chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I was exposed to Covid-19 on 12/31/2020. I think I had active Covid-19 when I got the second dose but I did not know . I was having muscle aches prior to getting the second shot. I had very bad muscle aches and was very fatigues. Three days after the vaccine I learned that I might have been exposed and tested positive that day. I had muscle aches and fatigue for ten days. Two weeks after the vaccine, I had terrible pressure on my chest.  My Oxygen level was still 97-98. I was very short of breath and had the feeling of chest pressure for three weeks. I am doing much better now.
A non-serious spontaneous report of FLUMIST given two days after expiration was received from a health professional concerning an eight-year-old male. Neither the patient's medical history nor the concomitant medications were reported. The product expired on 25-Dec-2011. On 27-Dec-2011, the patient received expired product. There was no adverse event associated with this medication error; therefore, treatment and reporter causality assessments are not applicable, and the event is considered resolved.
Sever flu symptoms (fever, chills, fatigue) for 24 hours and back/kidney pain at times.
After being very tired during afternoon of day following vaccination and about 29 minutes after eating light supper, felt very dizzy and after a while head fell back and blacked out for a while. About 10 minutes later, stood up and walked about 4 meters to the refrigerator, grabbed onto handles and my husband rushed over and grabbed me as ir seemed I was going to fall. Sat me down in sofa, where after short? while  I recovered. After getting up to go to refrigerator, no recollection of anything that followed. My internist?s diagnosis - síncope.
Tested positive for Covid-19 at home.  Treated with cough medicine occasionally. Symptoms: Fever first 5 days; vomiting first 2 days; coughing 3 weeks; fatigue: heavy first 5 days, gradually decreasing over next 2 weeks;    mild sneezing/runny nose/congestion 5 days
Fully vaccinated. Symptoms- congestion on 8/9/21, tested positive for covid on 8/12/21
Initial report was received from a consumer, who was also the patient, on 06 March 2012. A 43-year-old female patient had received a dose one intramuscular injection in the left deltoid of ADACEL, sanofi pasteur Ltd. (lot number not reported) on 23 February 2012. On 23 February 2012, the patient experienced muscle soreness in the left arm for a few days after the vaccine and went to the emergency room (ER). The patient had no movement/severe pain in the left arm since then and was getting worse so the patient went back to the ER. There was no redness at the injection site. The patient had no illness at the time of vaccination and no reported adverse events to prior vaccinations. The patient received no other vaccinations within four weeks of ADACEL and took no concomitant medications. The patient's past medical history included allergies to sulfa, codeine, ibuprofen and PROCARDIA. No further information was available at the time of the report. The patient's outcome was not recovered. Documents held by sender: None.
Loss of balance; This case was reported by a pharmacist via call center representative and described the occurrence of loss of balance in a 70-year-old female patient who received Herpes zoster (Shingrix) (batch number CL335, expiry date unknown) for prophylaxis.   On 29th October 2020, the patient received the 1st dose of Shingrix. On 2nd November 2020, 4 days after receiving Shingrix, the patient experienced loss of balance. On an unknown date, the outcome of the loss of balance was unknown.   It was unknown if the reporter considered the loss of balance to be related to Shingrix.  Additional details were received as follows: The age at vaccination was not reported.  The patient developed loss of balance within the first week after receiving the first dose of Shingrix, exact date or number of days was not specified. The reporter consented to follow up.
01/10/22 presents to ED for "SOB, N/V". PMHx of "DMII, HTN"
low oxygen; Weakness; A spontaneous report was received from a consumer concerning a 83-year-old, male patient, who received Moderna's COVID-19 Vaccine (mRNA-1273) and who experienced weakness, lack of efficacy and low oxygen.  The patient's medical history was included COVID 19,Pacemaker 20 years ago and Kidney Disease. Products known to have been used by the patient were not reported.  The patient received the first of two planned doses of mRNA-1273 (Batch number : 030L20A) on 22-Jan-2021.  On 1-Feb-2021, the patient experienced weakness, lack of efficacy and tested positive for COVID 19.   On 05 -Feb-2021, he was admitted in a hospital and treated with vitamin C, D, zinc cough.   On 15-Feb -2021, patient was discharged from the hospital.  On 03-Mar-2021, prior to the onset of the symptoms, the patient received the second of two planned doses of mRNA-1273 (Batch number: 002A21A), intramuscularly for prophylaxis of COVID-19 infection.  On 5-Mar -021, the patient experienced  low oxygen levels and admitted to a new hospital. Patient was consuming increasing supplemental oxygen as treatment.   No relevant laboratory details were included.   The patient received both scheduled doses of mRNA-1273 prior to the events; therefore, action taken with the drug in response to the events is not applicable.   The outcome of the events, experienced weakness, lack of efficacy and low oxygen were considered not recovered/ not resolved.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
9 Days after vaccine developed bloody diarrhea which lasted 24 and was followed by watery/ mucousy stools approximately 6 x day x past 5 days. Fever 102, no emesis.
Left arm pain,  headaches very bad,  stomach nausea still,  out of nowhere left upper outer thigh pain affects my walking due to pain, Memory issues, fatigue, no appetite, neck pain, Treating pain by myself with Tylenol and inactivity... grrrrrr very very bad for me to be inactive cannot perform duties I need to get done! Visceral liver pains and visceral stomach pains and lower gi pains. Heart palpitations. Leg aches calves.
patient administered with expired vaccine; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (patient administered with expired vaccine) in a 59-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 058F21A, 023C21A and 041B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 10-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Jul-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 08-Feb-2022 at 7:56 AM, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to .25 milliliter. On 08-Feb-2022 at 7:56 AM,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (patient administered with expired vaccine). On 08-Feb-2022 at 7:56 AM, EXPIRED PRODUCT ADMINISTERED (patient administered with expired vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported. Date the vial was initially stored in the refrigerator - 27Oct2021; 10:45am and the vial was first punctured - 08Feb2022; 7:45am. The vial stored post puncture in room temperature and Total amount of time the vial was exposed to room temperature range (8° to 25°C/46° to 77°F) was 1 hour. No treatment medications were reported.
Vaccine on 8-7-09. 8-10-09 elevated temp 104, nausea, vomiting (x1) severe nausea sore. No diarrhea. No local reaction. Swollen glands.  BRAT diet, elevated fluids, Prilosec OTC OD.
SUSPECTED CLINICAL VACCINATION FAILURE; SUSPECTED COVID-19 INFECTION/VERY SICK; This spontaneous report received from a patient concerned a 5 decade old female. Initial information was processed along with the additional information received on 26-JUL-2021 and 27-JUL-2021. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, 1 total administered on MAY-2021 for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported.  On 23-JUL-2021, the patient felt very sick with covid-19 infection which was clinically proven (suspected clinical vaccination failure and suspected covid-19 infection).  The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the suspected covid-19 infection/very sick and suspected clinical vaccination failure was not reported. This report was serious (Other Medically Important Condition). This report was associated with product quality complaint: 90000187073.; Sender's Comments: V0: 20210753056-COVID-19 VACCINE AD26.COV2.S-SUSPECTED CLINICAL VACCINATION FAILURE. This event is considered not related. The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event than the drug. Specifically: SPECIAL SITUATIONS
About 12 hours after the vaccination, I felt the "headrush" of a fever in my face behind my nose and eyes. My body was not warm like a fever so I did not take my temperature. However, I had a lot of difficulty sleeping that night because it felt like my body and immune system was revved up. It was impossible for me to get comfortable.
Moderna 4/19/21, 5/17/21, Pfizer 12/29/21. Positive on 7/28/22
This spontaneous report as received from a registered nurse refers to a 6 months old patient of unknown gender. The nurse reported that a patient received a pediatric dose of VAQTA earlier than recommended. The patient born on 12-DEC-2012, received the first dose of VAQTA (Lot number, expiry date, dose and route were not reported) on 13-JUN-2012, and second dose of VAQTA (Lot number, expiry date, dose and route were not reported) on 13-DEC-2012. No concomitant medications were reported. No adverse effect reported. Additional information has been requested.
Patient received a third dose of Moderna vaccine.  The administrator of the vaccine realized the patient had already received 2 doses after she had already administered the vaccine. The patient was monitored for 30 minutes, said she felt fine, and was advised to seek medical attention if she started having any adverse reaction.
31 year old male with concerns for vaccine allergy presents for initial consultation. He reports that he received his first COVID-19 vaccine (Pfizer) dose on 9 September 2021 and within an hour developed nausea, vomiting, malaise, myalgias, and chills which lasted for for the next four hours prior to resolving. He reports shortness of breath for the next several weeks but denies chest tightness, cough, wheezing, and chest pain. He denies laryngeal and cutaneous symptoms with this episode. By report, on 13 September he was diagnosed with COVID-19. Since late September/early October he has complained of muscle pain affecting his neck, back, and hips at baseline which then worsens throughout the day and becomes generalized if he does not not get adequate rest. He has been followed by Neurology for myositis and noted to have variably elevated CRP and CK levels (latter ranging from 200-8000 U/L). He also reports that since late September/early October he has had issues with low energy and libido and was diagnosed with pituitary dysfunction with low testosterone and elevated prolactin levels as well as transiently abnormal thyroid function studies. During this time he was also evaluated and treated for depression. Review of his history reveals prior complaints of chest pain and shortness of breath during BMT with normal cardiac workup at that time. He denies prior adverse vaccine reactions. He denies daytime, nocturnal, and exercise pulmonary symptoms except as noted above. He denies cutaneous symptoms outside of facial acne. He denies anosmia, sinus symptoms, and frequent sinopulmonary infections. He denies frequent GERD, dysphagia, impactions, and regurgitations. He denies suicidal ideation/plan.
This spontaneous prospective pregnancy report as received from a nurse practitioner and licensed practical nurse refers to a 24 year old female patient. On 07-FEB-2013, the patient was vaccinated with a first dose of VARIVAX (Merck) (lot #, expiry date, route of administration and dose were not reported) because the patient did not have immunity to ENGERIX-B. On 21-MAR-2013, the patient was vaccinated with a second dose of VARIVAX (Merck) (lot #, expiry date, route of administration and dose were not reported) and ENGERIX-B. On 04-APR-2013, the patient found out that she was pregnant. The last menstrual period (LMP) and estimated date of conception (EDD) were not known. The patient sought medical attention, she visited the office but no treatment was given to the patient. The pregnancy outcome was lost to follow-up. Additional information is not expected.
Severe nausea/vomiting, SOB, throat swelling, dizziness, headache, chills.  HRT recommended ED visit. She had IVF and Zofran. Symptoms improved.
11 to 12 hours after the shot, I feel mild itching on both sides of the tongue.
Localized redness and swelling at injection site within hours, lethargy, listlessness. 24 hours: vomiting and diarrhea, headache.  48 hours: continuing diarrhea, painful, stomach cramps, body aches, headache.  No fever during this time.
Patient developed fever on 12/9/2021, with mild cough and congestion.  Was treated at home with acetaminophen at approximately 12:30 pm, ibuprofen at 7:30 pm. Entire family was sick with similar symptoms.  2 siblings were positive for influenza and strep, Patient was not tested for either of those.  12/9 had a COVID pcr test done - negative.  On 12/10/21 mom went to check on her in the morning at 9:15, found patient n bed, not breathing, unresponsive. Attempted CPR with no response.  Final autopsy report pending. Parents report they received a call from medical examiner notifying ten that patient was tested + for influenza on post-mortem.
those yearly shots mess her up PERIOD; Initial information received on 01-Jan-2022 regarding an unsolicited valid Social Media non-serious case received from a consumer/non-hcp (non health care professional).  This case involves an unknown age female patient who's those yearly shots mess her up period while receiving vaccine INFLUENZA VACCINE.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer lot number not reported via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date the patient those yearly shots (full form not specified) her up period (ill-defined disorder) (unknown latency) following the administration of INFLUENZA VACCINE.  Action taken was not applicable.  It was not reported if the patient received a corrective treatment for the event (those yearly shots mess her up PERIOD).  At time of reporting, the outcome was Unknown for the event those yearly shots mess her up period.
Patient was instructed to remain in store for at least 15 minutes after vaccination to monitor for any adverse effects. She c/o tingling and numbness from shoulder to her fingers on the left arm (vaccine site) approximately 10-15 minutes after vaccine was administered. Symptoms persisted approx. 30 minutes after vaccine. Patient reported symptoms had improved and decided to leave the store; she smiled and waved before leaving pharmacy.
no other AE occurred/ No other AE; patient received a dose of MMRII on 11/19/2021 and product expired on 11/5/2021; This spontaneous report was received from a pharmacist referring to a patient of unreported age and gender. The patient's relevant medical history, drug reactions or allergies, and concomitant medications were not provided.  On 19-NOV-2021, the patient was vaccinated with one expired dose of measles, mumps, and rubella (wistar RA 27-3) virus vaccine, live recombinant human albumin (rHA) (M-M-R II) for prophylaxis (lot number S035355, expiration date 05-NOV-2021; dose number, vaccination scheme, route of administration, and anatomical location were not reported).   The product did not have any known temperature excursions. The pharmacist confirmed no other adverse events (AE) occurred (no adverse event).
Diarrhea; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea) and NAUSEA (Nausea) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026120A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no reported medical history).    On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1. On 13-Feb-2021, the patient experienced NAUSEA (Nausea). On 15-Feb-2021, the patient experienced DIARRHOEA (Diarrhea). The patient was treated with LOPERAMIDE HYDROCHLORIDE (IMODIUM) at an unspecified dose and frequency. At the time of the report, DIARRHOEA (Diarrhea) had not resolved and NAUSEA (Nausea) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
I received the Pfizer Bivalent COVID-19 booster on 10/5/2022. On 11/22/2022, my ears became blocked up, and I experienced head congestion. I also developed a very minor sore throat. On the morning of 11/23/2022, I took a home antigen test and quickly got a positive result. I contacted my NP, and she prescribed me PAXLOVID, which I began taking the evening of 11/23/2022. I took the full 5-day course. On about 11/28/2022, I took another home antigen test and got a negative result. I then developed head congestion, ear clogging, and a sore throat on 12/3/2022. I took another home test 12/4/2022 and got a positive result. I reached out to my NP, and she suggested that I take a PCR test, which I did on 12/7/2022. I was also tested for RSV and flu. I tested positive for COVID-19 and negative for RSV and the flu. The NP told me that I had one of the new strains of COVID-19, but she didn't mention which one. My symptoms gradually worsened. I had a severe cough and severe headache. I treated my symptoms with MUCINEX, ROBITUSSIN, TYLENOL, SUDAFED, and NYQUIL. The medicines helped a little, for the most part. The TYLENOL didn't get rid of the headaches, but the NYQUIL did help me sleep at night. The cough I experienced was a deep one; it was similar to the ones I've had when I had bronchitis in the past. On 12/11/2022, I took a home test and got a positive result, and when I took another on 12/16/2022, I got a negative result. However, the cough lasted beyond that, and it didn't ease up until about a week prior to the time of this writing. I feel fine now, but I sometimes have to clear my throat and still have the occasional cough. I started using a humidifier on 12/26/2022, and I didn't stop using it until 1/3/2023. I still have a residual headache, but it is intermittent, and it's not severe enough to require medicine.
Patient states arm has hard lump at injection site.  She states that there are 2 large red spots near the injection site that are really itching.  Patient states that there seems to be some numbness in her left hand that she is not sure  if it is due to the vaccine.
felt pretty lousy/not as bad as the second dose; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (felt pretty lousy/not as bad as the second dose) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031L20A and 013L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In February 2021, the patient experienced FEELING ABNORMAL (felt pretty lousy/not as bad as the second dose). At the time of the report, FEELING ABNORMAL (felt pretty lousy/not as bad as the second dose) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant and treatment drug information was provided.   This case was linked to (Patient Link).
When the vaccinator injected the vaccine they told the patient that there was some blood; she felt a weird irritation of the skin; she felt a weird irritation of the skin and a little bite of sore arm; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE HAEMORRHAGE (When the vaccinator injected the vaccine they told the patient that there was some blood), SKIN IRRITATION (she felt a weird irritation of the skin) and PAIN IN EXTREMITY (she felt a weird irritation of the skin and a little bite of sore arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COVID-19 vaccination (First dose of Covid-19 vaccination.).   On 16-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INJECTION SITE HAEMORRHAGE (When the vaccinator injected the vaccine they told the patient that there was some blood), SKIN IRRITATION (she felt a weird irritation of the skin) and PAIN IN EXTREMITY (she felt a weird irritation of the skin and a little bite of sore arm). The patient was treated with Wound care (vaccinator cleansed the injection site then rubbed it alcohol) for Injection site haemorrhage. At the time of the report, INJECTION SITE HAEMORRHAGE (When the vaccinator injected the vaccine they told the patient that there was some blood), SKIN IRRITATION (she felt a weird irritation of the skin) and PAIN IN EXTREMITY (she felt a weird irritation of the skin and a little bite of sore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient stated that she had less symptoms with the second dose of the covid-19 vaccination compared to the first dose.   This case was linked to US-MODERNATX, INC.-MOD-2021-081491 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-081491:Original Case : MOD-2021-081491 Case for Dose 2
syncope, numbness, paresthesia Narrative:  Observed receiving vaccination with <1-2 seconds of syncope - which she notes is typical for her. No physical or mental deficits after this episode. Conversation was immediately able to be picked-up upon awakening. No loss of bowel/bladder. About 2-3 minutes post vaccination, she noted tongue numbness and recoccurance of mild paresthesia in b/l fingers. Speech was intermittently affected by report of numb tongue, but remained intelligible. She denied any type of swelling. No other s/sx of immediate allergic reaction or angioedema. O: GEN: not in apparent distress, answering questions appropriately and in full sentences w/o increased respiratory effort HEENT: throat non-erythematous, no swelling over any aspect of face or inside of mouth Neck: no swelling, no stridor Pulm: CTAB, no wheezes Ext: moves all 4 spontaneously, no edema Neuro: no focal deficits, grip 5/5 b/l, no different in sensation to light touch over b/l UE, neck or face
Pt recvd 3 doses of Engerix-B & exp fatigue, sore throat, aching joints & lupus sx;